{"id":739699,"date":"2023-03-14T06:03:05","date_gmt":"2023-03-14T10:03:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"modified":"2023-03-14T06:03:05","modified_gmt":"2023-03-14T10:03:05","slug":"stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","title":{"rendered":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"},"content":{"rendered":"

<\/p>\n

Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum<\/b><\/p>\n

PIOMBINO DESE, Italy–(BUSINESS WIRE<\/a>)–
\nStevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023.\n<\/p>\n

\nThe Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company\u2019s website at www.stevanatogroup.com<\/a> under the “Investors” section of the website. A replay will be available for approximately 90 days after the event.\n<\/p>\n

About Stevanato Group<\/b><\/p>\n

\nFounded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group\u2019s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.\n<\/p>\n

\nFor more information, please visit www.stevanatogroup.com<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230314005400\/en\/<\/a><\/span><\/p>\n

Media
\n<\/b>
Stevanato Group
\n
media@stevanatogroup.com<\/a><\/p>\n

Investor Relations
\n<\/b>
Lisa Miles
\n
lisa.miles@stevanatogroup.com<\/a><\/p>\n

KEYWORDS:<\/b> Italy Europe<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology General Health Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum PIOMBINO DESE, Italy–(BUSINESS WIRE)– Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023. The Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company\u2019s website at www.stevanatogroup.com under the “Investors” section of the website. A replay will be available for approximately 90 days after the event. About Stevanato Group Founded in … <\/p>\n

Continue reading “Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-739699","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nStevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum PIOMBINO DESE, Italy–(BUSINESS WIRE)– Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023. The Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company\u2019s website at www.stevanatogroup.com under the “Investors” section of the website. A replay will be available for approximately 90 days after the event. About Stevanato Group Founded in … Continue reading "Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T10:03:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\",\"datePublished\":\"2023-03-14T10:03:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"},\"wordCount\":266,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\",\"name\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-03-14T10:03:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_locale":"en_US","og_type":"article","og_title":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","og_description":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum PIOMBINO DESE, Italy–(BUSINESS WIRE)– Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023. The Company will present on Tuesday, March 21, 2023 at 11:15 a.m. ET. A live audio webcast will be available on the Company\u2019s website at www.stevanatogroup.com under the “Investors” section of the website. A replay will be available for approximately 90 days after the event. About Stevanato Group Founded in … Continue reading \"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-14T10:03:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum","datePublished":"2023-03-14T10:03:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"},"wordCount":266,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/","name":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-03-14T10:03:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230314005400r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stevanato-group-to-present-at-keybanc-capital-markets-life-sciences-medtech-investor-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=739699"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/739699\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=739699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=739699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=739699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}